Search by Drug Name or NDC

NDC 42291-0421-30 LEFLUNOMIDE 20 mg/1 Details

LEFLUNOMIDE 20 mg/1

LEFLUNOMIDE is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by AvKARE. The primary component is LEFLUNOMIDE.

MedlinePlus Drug Summary

Leflunomide is used alone or in combination with other medications to treat rheumatoid arthritis (a condition in which the body attacks its own joints, causing pain, swelling, and loss of function). Leflunomide is in a class of medications called disease-modifying antirheumatic drugs (DMARDs). It works by decreasing inflammation and slowing the progress of the condition, which can help improve the physical activity of people with rheumatoid arthritis.

Related Packages: 42291-0421-30
Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Leflunomide

Product Information

NDC	42291-0421
Product ID	42291-421_0e8fcbb3-196d-92c2-e063-6294a90a392b
Associated GPIs	66280050000320
GCN Sequence Number	040550
GCN Sequence Number Description	leflunomide TABLET 20 MG ORAL
HIC3	S2I
HIC3 Description	ANTI-INFLAMMATORY, PYRIMIDINE SYNTHESIS INHIBITOR
GCN	67032
HICL Sequence Number	018694
HICL Sequence Number Description	LEFLUNOMIDE
Brand/Generic	Generic
Proprietary Name	LEFLUNOMIDE
Proprietary Name Suffix	n/a
Non-Proprietary Name	LEFLUNOMIDE
Product Type	HUMAN PRESCRIPTION DRUG
Dosage Form	TABLET
Route	ORAL
Active Ingredient Strength	20
Active Ingredient Units	mg/1
Substance Name	LEFLUNOMIDE
Labeler Name	AvKARE
Pharmaceutical Class	Antirheumatic Agent [EPC]
DEA Schedule	n/a
Marketing Category	ANDA
Application Number	ANDA077090
Listing Certified Through	2025-12-31

Package

NDC 42291-0421-30 (42291042130)

Pricing Information	N/A
NDC Package Code	42291-421-30
Billing NDC	42291042130
Package	30 TABLET in 1 BOTTLE (42291-421-30)
Marketing Start Date	2019-06-13
NDC Exclude Flag	N